Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

Vall d'Hebron and the National Art Museum of Catalonia come together to promote new treatments through art

This collaboration agreement will begin with a project aimed at studying new art health therapies in the field of psychology.

News

A study confirms the validity of the ROX index to determine the need to intubate a patient with acute respiratory failure treated with high-flow oxygen therapy

Researchers have defined a predictor of success or failure to detect which patients will respond positively to therapy and not delay intubation in those who will not.

News

Antibiotics can become a new weapon against cancer by decreasing tumor growth

Researchers from VHIR have shown for the first time in vivo that bactericidal antibiotics in combination with autophagy blockers decrease tumor growth.

News

The oncological research of the VHIR united in the World Cancer Day

This morning, researchers from all the VHIR research groups belonging to the Oncology area gathered at the doors of the Collserola building to show their fight against cancer through research.

News

A study recommends reconsidering Hepatitis A vaccination protocol to prevent a vaccine-resistant virus

Researchers have analyzed the evolution of hepatitis A virus in vaccinated and unvaccinated patients with massive sequencing techniques.

News

Vall d'Hebron launches a campaign to promote the research for children's heart diseases

The campaign #VHTocaElCor aims to raise awareness about the importance of childhood heart diseases and promote research in this field.

News

One study determines the mortality and predictors of long-term survival of patients with chronic hypersensitivity pneumonitis

Patients with chronic hypersensitivity pneumonitis (CHN) live an average of 7 years.

News

The Easysims innovation project of VHIR selected to receive the support of CIMTI

Easysims becomes the second project of the VHIR selected to receive support from CIMIT in the two years of operation of this initiative created in 2017.

News

Genetic predisposition favors cannabis use in people with ADHD

People with ADHD are almost eight times more likely to use cannabis throughout their lives. The study has described four shared genetic regions in both disorders. The prevalence rate of substance use disorder in adult ADHD is 45%.

News

The Association Llavaneres Contra el Càncer hands €10.000 for the research at childish sarcomas

Peromissi The Association Llavaneres Contra el Càncer organized several acts to collect money and fund with it the VHIRs' research on new therapies for the childish sacormas.

News

Dr. Rosa Burgos receives a Sanitat Baix Llobregat Award from the College of Physicians of Barcelona

The awards reward research aimed at improving the effectiveness and efficiency of health services.

News

Dr. Maria Buti, among world's most cited researchers

In its list of the world's most cited researchers, Clarivate Analytics includes Dr. Maria Buti, principal investigator of the Liver Diseases research group at VHIR.

News

A research work on psychotropic medication awarded at the Annual Meeting of the Catalan Society of Infantile-Juvenile Psychiatry

The work collects data on the evolution of the prescription of psychotropic medication in the child and youth population in Catalonia compared to the Nordic countries.

News

Two projects from the Infectious Diseases research group receive a Gilead Grant

Dr. Meritxell Genescà and Dr. Vicenç Falcó awarded with a Grant from the biopharmaceutical company Gilead.

News

The Community of Madrid awards Dr. Esperanza Zuriguel for her research in health care

The Nursing Care Research Awards aim to shed light on the contribution of Spanish nurses to health care research.

News

Bones Festes plenes de #GestosQueCuren

Aquestes festes, posem a les teves mans les tiretes que converteixen les petites ferides en somriures. Els diners recaptats aniran destinats a impulsar la recerca i la innovació i fer que la medicina avanci.

News

Vall d'Hebron and NBD team up to develop a new treatment for Dent's disease

Vall d'Hebron and the biotechnological company NDB are working together to develop new drugs for the Dent's disease with supercomputing technology.

News

A clinical trial demonstrates the positive effect of personalized vaccines in brain cancer

Researchers opt for a personalized approach to the treatment of glioblastoma consisting of two immunotherapy vaccines.

News

New study between the VHIR and the UB on autonomic dysfunction in patients with CFG and other CSS, with support of the ACAF

The VHIR and the UB jointly carry out a study on dysautonomia and circadian rhythms in patients with chronic fatigue syndrome and other central sensitization syndromes, with the support of the ACAF.

News

El Dr. Mervyn Singer ha estat el protagonista de la 22a Conferència Anual de Vall d’Hebron

Durant 3 dies, el Pavelló Docent de l'hospital ha acollit més de 35 presentacions orals i 125 pòsters de la 12a Jornada Científica del VHIR.